EUVIMEDEUVIMED entdecken
Crossref

Time‐Dependent Diffusion MRI ‐Based Microstructural Mapping for Characterizing HER2 ‐Zero, ‐Low, ‐Ultra‐Low, and ‐Positive Breast Cancer

Xiaoxia Wang, Yao Huang, Ying Cao, Huifang Chen, Xueqin Gong, Xiaosong Lan, Jiuquan Zhang iD, Zhaoxiang Ye iD

Journal of Magnetic Resonance Imaging · 2025

DOI: 10.1002/jmri.70074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, 2025. Verfasst von Xiaoxia Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Res…. Hauptthemen laut MEDLINE: Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Diffusion Magnetic Resonance Imaging. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Tianjin Key Medical Discipline (Specialty) Construction Project, the Fundamental Research Funds for the Central Universities, Chongqing Medical Research Project of Combination of Science and Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

With breast cancer treatment advances, accurate non‐invasive methods are needed to distinguish its human epidermal growth factor receptor 2 (HER2) subtypes. Recently developed time‐dependent diffusion MRI ( t d ‐dMRI) has potential in characterizing cellular tissue microstructures in breast cancer. However, its role in identifying HER2 subtypes is unknown.

Purpose

To investigate the feasibility of t d ‐dMRI‐based microstructural histogram parameters for characterizing properties of four HER2 subtypes in breast cancer. Study Type Prospective. Population Four hundred ninety‐five participants with invasive breast cancer (18 HER2‐zero, 49 ‐ultralow, 243 ‐low and 185 ‐positive). Field Strength/Sequence 3‐T, oscillating gradient spin‐echo (OGSE) and pulsed gradient spin‐echo (PGSE) sequences for t d ‐dMRI. Assessment The HER2 status was categorized as HER2‐zero, ‐ultralow, ‐low, or ‐positive by immunohistochemistry and fluorescence in situ hybridization. The t d ‐dMRI data were fitted using the IMPULSED method. Tumors were identified on dynamic contrast‐enhanced MRI and delineated on the PGSE image ( b = 0 s/mm 2 ). Forty‐nine histogram parameters were extracted from the tumor, including four microstructural maps (diameter, intracellular fraction, extracellular diffusivity, cellularity) and three apparent diffusion coefficient maps. Statistical Tests Histogram parameters were analyzed via one‐way analysis of variance followed by pairwise t tests with Bonferroni correction. The Boruta method selected the significant parameters for each HER2 subtype. The predictive performance was assessed through area under the curve (AUC). A p value < 0.05 was considered statistically significant.

Results

Thirty‐two histogram parameters showed significant differences among the four HER2 subgroups. Four models were constructed, which achieved high performance for distinguishing HER2 ‐positive versus negative ( AUC of 0.85), HER2 ‐positive versus low ( AUC of 0.87), and HER2 ‐low versus immunohistochemistry 0 ( AUC of 0.81), along with moderate performance for distinguishing HER2 ‐zero versus ‐ultralow ( AUC of 0.77). Data Conclusion Selected t d ‐dMRI–derived histogram parameters may be applicable for identifying HER2 subtypes in breast cancer. Level of Evidence 1. Technical Efficacy Stage 2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesDiffusion Magnetic Resonance ImagingHumansFemaleMiddle AgedProspective StudiesAdultAgedImmunohistochemistryBreastIn Situ Hybridization, FluorescenceReproducibility of ResultsImage Processing, Computer-Assisted

Stichwörter der Autor:innen

breast neoplasmhuman epidermal growth factor receptor 2time‐dependent diffusion MRI

Substanzen

Erb-b2 Receptor Tyrosine KinasesERBB2 protein, human

Autor:innen und Institutionen

  • Department of Radiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention an…
  • Department of Radiology, Chongqing University Cancer Hospital, Chongqing, China.

ORCID-Profile: Jiuquan Zhang, Zhaoxiang Ye

Förderung

  • Tianjin Key Medical Discipline (Specialty) Construction Project
  • the Fundamental Research Funds for the Central Universities
  • Chongqing Medical Research Project of Combination of Science and Medicine
  • the Chongqing University Cancer Hospital Scientific Research Capacity Improvement Project
  • the Natural Science Foundation of Chongqing municipality
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Wang, X., Huang, Y., Cao, Y., Chen, H., Gong, X., Lan, X., Zhang, J., & Ye, Z. (2025). Time‐Dependent Diffusion MRI ‐Based Microstructural Mapping for Characterizing HER2 ‐Zero, ‐Low, ‐Ultra‐Low, and ‐Positive Breast Cancer. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.70074

Vancouver

Wang X, Huang Y, Cao Y, Chen H, Gong X, Lan X, et al. Time‐Dependent Diffusion MRI ‐Based Microstructural Mapping for Characterizing HER2 ‐Zero, ‐Low, ‐Ultra‐Low, and ‐Positive Breast Cancer. Journal of Magnetic Resonance Imaging. 2025. doi:10.1002/jmri.70074

BibTeX
@article{Wang2025,
  author = {Wang, Xiaoxia and Huang, Yao and Cao, Ying and Chen, Huifang and Gong, Xueqin and Lan, Xiaosong and Zhang, Jiuquan and Ye, Zhaoxiang},
  title = {Time‐Dependent Diffusion MRI ‐Based Microstructural Mapping for Characterizing HER2 ‐Zero, ‐Low, ‐Ultra‐Low, and ‐Positive Breast Cancer},
  journal = {Journal of Magnetic Resonance Imaging},
  year = {2025},
  doi = {10.1002/jmri.70074}
}
Kostenlos starten →